Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net income	$ 254,524	$ 178,301
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property	16,598	16,215
Amortization of intangibles	23,189	24,096
Provision for losses on accounts receivable	4,676	2,905
Amortization of stock options and appreciation rights	2,322	2,897
Other share-based compensation expense	7,419	6,064
Changes in operating assets and liabilities, net of acquisitions	(142,092)	(106,136)
Other, net	(2,609)	9,481
Net Cash provided by Operating Activities	164,027	133,823
Cash Flows from Investing Activities
Acquisition of businesses, net of cash acquired	(35,667)	(6,974)
Capital expenditures	(20,809)	(11,674)
Proceeds from property sales	226	494
Life insurance proceeds	0	3,159
Cash payments for loans on company-owned life insurance	0	(14,835)
Net Cash used in Investing Activities	(56,250)	(29,830)
Cash Flows from Financing Activities
Net (repayments) borrowings under revolving credit facility	(27,000)	442,592
Long-term debt repayments	40,185	550,432
Interest rate swap settlement receipts (payments)	(5,501)	4,812
Payment of debt issuance costs	0	(1,956)
Purchases of treasury shares	(716)	(13,604)
Dividends paid	(39,829)	(38,612)
Acquisition holdback payments	1,510	2,361
Exercise of stock options and appreciation rights	127	224
Taxes paid for shares withheld for equity awards	(7,914)	(4,405)
Net Cash used in Financing Activities	(111,526)	(173,366)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	1,402	(288)
Decrease in Cash and Cash Equivalents	(2,347)	(69,661)
Cash and Cash Equivalents at Beginning of Period	184,474	257,745
Cash and Cash Equivalents at End of Period	$ 182,127	$ 188,084